All News #Library
MSD`s Biological Pembrolizumab Receives Supplemental Approval in US
17 Aug 2018 //
FDA
Merck Sharp Dohme`s Biological Pembrolizumab Receives Approval in US
17 Aug 2018 //
FDA
Merck Sharp Dohme Pembrolizumab Receives Supplemental Approval In US
11 May 2017 //
FDA

Market Place
Sourcing Support